NCT02727660: A trial that was reported late by Pearl Therapeutics, Inc.
This trial has reported, although it was 48 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT02727660 |
|---|---|
| Title | A Randomized, Double-Blind, Parallel Group, Multi-Center Study to Assess the Efficacy and Safety of PT009 Compared to PT005 on COPD Exacerbations Over a 52-Week Treatment Period in Subjects With Moderate to Very Severe COPD |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | April 29, 2016 |
| Completion date | April 4, 2018 |
| Required reporting date | April 4, 2019, midnight |
| Actual reporting date | May 22, 2019 |
| Date last checked at ClinicalTrials.gov | Dec. 5, 2025 |
| Days late | 48 |